506 related articles for article (PubMed ID: 21216540)
1. One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions.
Martelli P; Ferrari L; Morganti M; De Angelis E; Bonilauri P; Guazzetti S; Caleffi A; Borghetti P
Vet Microbiol; 2011 May; 149(3-4):339-51. PubMed ID: 21216540
[TBL] [Abstract][Full Text] [Related]
2. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
[TBL] [Abstract][Full Text] [Related]
3. [Field trial on the simultaneous vaccination against porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae].
Herbich E; Heissenberger B; Ladinig A; Griessler A; Ritzmann M; Weissenbacher-Lang C; Hennig-Pauka I
Tierarztl Prax Ausg G Grosstiere Nutztiere; 2013; 41(5):279-88. PubMed ID: 24126996
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled study on the efficacy of a novel combination vaccine against enzootic pneumonia (Mycoplasma hyopneumoniae) and porcine Circovirus type 2 (PCV2) in the presence of strong maternally derived PCV2 immunity in pigs.
Tassis PD; Tsakmakidis I; Papatsiros VG; Koulialis D; Nell T; Brellou G; Tzika ED
BMC Vet Res; 2017 Apr; 13(1):91. PubMed ID: 28388953
[TBL] [Abstract][Full Text] [Related]
5. Concurrent vaccinations against PCV2 and PRRSV: study on the specific immunity and clinical protection in naturally infected pigs.
Martelli P; Ardigò P; Ferrari L; Morganti M; De Angelis E; Bonilauri P; Luppi A; Guazzetti S; Caleffi A; Borghetti P
Vet Microbiol; 2013 Mar; 162(2-4):558-571. PubMed ID: 23206413
[TBL] [Abstract][Full Text] [Related]
6. Impact of maternally derived immunity on piglets' immune response and protection against porcine circovirus type 2 (PCV2) after vaccination against PCV2 at different age.
Martelli P; Saleri R; Ferrarini G; De Angelis E; Cavalli V; Benetti M; Ferrari L; Canelli E; Bonilauri P; Arioli E; Caleffi A; Nathues H; Borghetti P
BMC Vet Res; 2016 May; 12():77. PubMed ID: 27170186
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with a Porcine Reproductive and Respiratory Syndrome (PRRS) Modified Live Virus Vaccine Followed by Challenge with PRRS Virus and Porcine Circovirus Type 2 (PCV2) Protects against PRRS but Enhances PCV2 Replication and Pathogenesis Compared to Results for Nonvaccinated Cochallenged Controls.
Niederwerder MC; Bawa B; Serão NV; Trible BR; Kerrigan MA; Lunney JK; Dekkers JC; Rowland RR
Clin Vaccine Immunol; 2015 Dec; 22(12):1244-54. PubMed ID: 26446422
[TBL] [Abstract][Full Text] [Related]
8. One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model.
Fort M; Sibila M; Pérez-Martín E; Nofrarías M; Mateu E; Segalés J
Vaccine; 2009 Jun; 27(30):4031-7. PubMed ID: 19379787
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 3 vaccination strategies against porcine reproductive and respiratory syndrome virus,
Jeong J; Kang I; Kim S; Park KH; Park C; Chae C
Can J Vet Res; 2018 Jan; 82(1):39-47. PubMed ID: 29382967
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the efficacy of a trivalent vaccine mixture against a triple challenge with Mycoplasma hyopneumoniae, PCV2, and PRRSV and the efficacy comparison of the respective monovalent vaccines against a single challenge.
Oh T; Park KH; Yang S; Jeong J; Kang I; Park C; Chae C
BMC Vet Res; 2019 Oct; 15(1):342. PubMed ID: 31619295
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine.
Fort M; Sibila M; Nofrarías M; Pérez-Martín E; Olvera A; Mateu E; Segalés J
Vet Immunol Immunopathol; 2012 Nov; 150(1-2):128-32. PubMed ID: 23010221
[TBL] [Abstract][Full Text] [Related]
12. Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection.
Opriessnig T; Madson DM; Prickett JR; Kuhar D; Lunney JK; Elsener J; Halbur PG
Vet Microbiol; 2008 Sep; 131(1-2):103-14. PubMed ID: 18430525
[TBL] [Abstract][Full Text] [Related]
13. Influence of age on the effectiveness of PCV2 vaccination in piglets with high levels of maternally derived antibodies.
Haake M; Palzer A; Rist B; Weissenbacher-Lang C; Fachinger V; Eggen A; Ritzmann M; Eddicks M
Vet Microbiol; 2014 Jan; 168(2-4):272-80. PubMed ID: 24315042
[TBL] [Abstract][Full Text] [Related]
14. The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex.
Fachinger V; Bischoff R; Jedidia SB; Saalmüller A; Elbers K
Vaccine; 2008 Mar; 26(11):1488-99. PubMed ID: 18304705
[TBL] [Abstract][Full Text] [Related]
15. Clinical, virological, immunological and pathological evaluation of four porcine circovirus type 2 vaccines.
Seo HW; Han K; Park C; Chae C
Vet J; 2014 Apr; 200(1):65-70. PubMed ID: 24618398
[TBL] [Abstract][Full Text] [Related]
16. Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus.
Tian D; Sooryanarain H; Matzinger SR; Gauger PC; Karuppannan AK; Elankumaran S; Opriessnig T; Meng XJ
J Gen Virol; 2017 Dec; 98(12):3026-3036. PubMed ID: 29091579
[TBL] [Abstract][Full Text] [Related]
17. A new single-dose bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae elicits protective immunity and improves growth performance under field conditions.
Jeong J; Park C; Choi K; Chae C
Vet Microbiol; 2016 Jan; 182():178-86. PubMed ID: 26711046
[TBL] [Abstract][Full Text] [Related]
18. A Porcine circovirus type 2b (PCV2b)-based experimental vaccine is effective in the PCV2b-Mycoplasma hyopneumoniae coinfection pig model.
Opriessnig T; Castro AMMG; Karuppanan AK; Gauger PC; Halbur PG; Matzinger SR; Meng XJ
Vaccine; 2019 Oct; 37(44):6688-6695. PubMed ID: 31537445
[TBL] [Abstract][Full Text] [Related]
19. Effect of high and low levels of maternally derived antibodies on porcine circovirus type 2 (PCV2) infection dynamics and production parameters in PCV2 vaccinated pigs under field conditions.
Feng H; Segalés J; Fraile L; López-Soria S; Sibila M
Vaccine; 2016 Jun; 34(27):3044-3050. PubMed ID: 27155497
[TBL] [Abstract][Full Text] [Related]
20. Porcine reproductive and respiratory syndrome virus infection at the time of porcine circovirus type 2 vaccination has no impact on vaccine efficacy.
Sinha A; Shen HG; Schalk S; Beach NM; Huang YW; Halbur PG; Meng XJ; Opriessnig T
Clin Vaccine Immunol; 2010 Dec; 17(12):1940-5. PubMed ID: 20926694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
